"But we at AbbVie are indeed planning to cooperate with Aetna Pharmaceuticals."

"As for the specific content of the cooperation, it is not convenient to disclose it to the public for the time being. Please forgive me."

Faced with many questions from reporters, Gao Tianlong's answers were also very simple.

Of course, he hadn't reached a cooperation in the first place, so there was no way it couldn't be simple.

However, Chen Xuan rejected Abovie's offer outright, and this must not be made public.

Not only will it let other competitors know AbbVie's trump card, but it will also have a negative impact on AbbVie, causing stock price fluctuations.

Therefore, he could only say that he had no comment and simply revealed that both parties had the intention to cooperate.

This sentence is ambiguous and is not an answer at all.

Having the intention to cooperate but ultimately not cooperating also fits the meaning of this sentence.

Most importantly, it can also send a signal to the outside world, making it think that Abovie and Antai Pharmaceutical Group have really started cooperation.

This signal is good news for AbbVie, and will also successfully mislead competitors and cause them to misjudge.

After saying what needs to be said,

Gao Tianlong did not reveal any other information and just got into the car and left.

This left all the reporters and onlookers dumbfounded.

Is this cooperation or not?

Did AbbVie acquire Chen Xuan’s formula?

"What's the point? You're only talking halfway?"

"Are there any intentions to cooperate? Does that mean that AbbVie has already made an offer, Chen Xuan has agreed, and both parties are waiting to sign the contract?"

"No way! Is AbbVie really going to acquire the new drug formula? Will this kind of black-hearted capital take away this miracle drug for lung cancer?"

"It's not just the formula for the lung cancer drug, it's very likely that the entire Antai Pharmaceutical Group was sold to AbbVie."

"What? What nonsense are you talking about? How could Chen Xuan possibly sell Antai Pharmaceutical Group? Is he going to work for AbbVie? What price would AbbVie have to pay for him to agree to such terms?"

"AbbVie is incredibly wealthy. Its revenue last year was $500 billion. Do you think it can't afford this price?"

"Is Chen Xuan really that short-sighted? Would he really sell himself to AbbVie? No! This news is terrible."

……

……

Gao Tianlong revealed nothing.

But the speculations on the Internet are all kinds of strange and bizarre, and they become more and more mysterious as they spread.

It is said that the cooperation between the two parties has been completed and AbbVie has successfully obtained the patent for the new drug formula.

The next step is to complete the signing procedures.

After all, AbbVie is a giant international pharmaceutical company with deep pockets, so it is impossible for it to fail.

Previously, Novartis was able to acquire the formula of a special liver cancer drug with 50 billion yuan. So AbbVie, which is stronger than Novartis, should be able to do the same.

And AbbVie came well prepared this time. Everyone knows that they have prepared a sky-high price?

In this situation, everyone believed that AbbVie would definitely succeed in the acquisition and there was almost no possibility of failure.

This speculation also made countless people nervous. Everyone really believed that AbbVie had acquired the new drug formula, which meant that a sky-high price was inevitable.

After all, AbbVie has never sold low-priced drugs in its past history.

Therefore, as long as the formula for the lung cancer drug falls into the hands of AbbVie, it is destined to be a sky-high priced drug that the poor cannot afford.

This news made countless people wail.

As for AbbVie, it also acquired Antai Pharmaceutical Group and became the largest shareholder of Antai Pharmaceutical Group.

This made everyone feel that there was no problem.

Chen Xuan even sold the formula for a special lung cancer drug, so it's normal for him to sell the pharmaceutical company as well.

It is almost a common understanding among everyone that he would definitely be willing to sell Antai Pharmaceutical Group as long as AbbVie's bid was high enough.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like